Literature DB >> 23021973

Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology.

A Carlo Altamura1, Sara Pozzoli, Alessio Fiorentini, Bernardo Dell'osso.   

Abstract

As for other major psychoses, the etiology of schizophrenia still remains poorly understood, involving genetic and epigenetic mechanisms, as well as environmental contributions. In addition, immune alterations have been widely reported in schizophrenic patients, involving both the unspecific and specific pathways of the immune system, and suggesting that infectious/autoimmune processes play an important role in the etiopathogenesis of the disorder. Cytokines, in particular, are supposed to play a critical role in infectious and inflammatory processes, mediating the cross-talk between the brain and the immune system. In this perspective, even though mixed results have been reported, it seems that schizophrenia is associated with an imbalance in inflammatory cytokines. Alterations in the inflammatory and immune systems, moreover, seem to be already present in the early stages of schizophrenia and connected to the neurodevelopmental hypothesis of the disorder, identifying its roots in brain development abnormalities that do not manifest themselves until adolescence or early adulthood. At the same time, neuropathological and longitudinal studies in schizophrenia also support a neurodegenerative hypothesis and, more recently, a novel mixed hypothesis, integrating neurodevelopmental and neurodegenerative models, has been put forward. The present review aims to provide an updated overview of the connections between the immune and inflammatory alterations and the aforementioned hypotheses in schizophrenia.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23021973     DOI: 10.1016/j.pnpbp.2012.08.015

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  20 in total

Review 1.  Search for missing schizophrenia genes will require a new developmental neurogenomic perspective.

Authors:  H B Kiran Kumar; Christina Castellani; Sujit Maiti; Richard O'Reilly; Shiva M Singh
Journal:  J Genet       Date:  2013       Impact factor: 1.166

2.  Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.

Authors:  Parita Shah; Yusuke Iwata; Eric E Brown; Julia Kim; Marcos Sanches; Hiroyoshi Takeuchi; Shinichiro Nakajima; Margaret Hahn; Gary Remington; Philip Gerretsen; Ariel Graff-Guerrero
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08-19       Impact factor: 5.270

3.  Smoking and Serum Lipid Profiles in Schizophrenia.

Authors:  Hui-Mei An; Yun-Long Tan; Shu-Ping Tan; Jing Shi; Zhi-Ren Wang; Fu-De Yang; Xu-Feng Huang; Jair C Soars; Thomas R Kosten; Xiang-Yang Zhang
Journal:  Neurosci Bull       Date:  2016-03-28       Impact factor: 5.203

4.  Dynein Separately Partners with NDE1 and Dynactin To Orchestrate T Cell Focused Secretion.

Authors:  Shubhankar Nath; Laura Christian; Sarah Youngsun Tan; Sanghee Ki; Lauren I R Ehrlich; Martin Poenie
Journal:  J Immunol       Date:  2016-08-17       Impact factor: 5.422

Review 5.  Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications.

Authors:  Monojit Debnath; Michael Berk
Journal:  Schizophr Bull       Date:  2014-04-07       Impact factor: 9.306

6.  Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial.

Authors:  Faith B Dickerson; Cassie Stallings; Andrea Origoni; Emily Katsafanas; Christina L G Savage; Lucy A B Schweinfurth; Joshana Goga; Sunil Khushalani; Robert H Yolken
Journal:  Prim Care Companion CNS Disord       Date:  2014-02-13

7.  Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice.

Authors:  Se Jin Park; Jee Youn Lee; Sang Jeong Kim; Se-Young Choi; Tae Young Yune; Jong Hoon Ryu
Journal:  Sci Rep       Date:  2015-02-17       Impact factor: 4.379

Review 8.  Neurodevelopmental and environmental hypotheses of negative symptoms of schizophrenia.

Authors:  Frédéric Limosin
Journal:  BMC Psychiatry       Date:  2014-03-26       Impact factor: 3.630

9.  Systems biology, bioinformatics, and biomarkers in neuropsychiatry.

Authors:  Ali Alawieh; Fadi A Zaraket; Jian-Liang Li; Stefania Mondello; Amaly Nokkari; Mahdi Razafsha; Bilal Fadlallah; Rose-Mary Boustany; Firas H Kobeissy
Journal:  Front Neurosci       Date:  2012-12-24       Impact factor: 4.677

Review 10.  Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia.

Authors:  Katina Aleksovska; Emanuele Leoncini; Stefano Bonassi; Alfredo Cesario; Stefania Boccia; Alessandra Frustaci
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.